These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22903061)

  • 1. A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors.
    Vicente-Dueñas C; Romero-Camarero I; González-Herrero I; Alonso-Escudero E; Abollo-Jiménez F; Jiang X; Gutierrez NC; Orfao A; Marín N; Villar LM; Criado MC; Pintado B; Flores T; Alonso-López D; De Las Rivas J; Jiménez R; Criado FJ; Cenador MB; Lossos IS; Cobaleda C; Sánchez-García I
    EMBO J; 2012 Sep; 31(18):3704-17. PubMed ID: 22903061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of p53 exacerbates multiple myeloma phenotype by facilitating the reprogramming of hematopoietic stem/progenitor cells to malignant plasma cells by MafB.
    Vicente-Dueñas C; González-Herrero I; García Cenador MB; García Criado FJ; Sánchez-García I
    Cell Cycle; 2012 Oct; 11(20):3896-900. PubMed ID: 22983007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of primary MAFB target genes in multiple myeloma.
    van Stralen E; van de Wetering M; Agnelli L; Neri A; Clevers HC; Bast BJ
    Exp Hematol; 2009 Jan; 37(1):78-86. PubMed ID: 19013005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cellular architecture of multiple myeloma.
    Vicente-Dueñas C; Romero-Camarero I; García-Criado FJ; Cobaleda C; Sánchez-García I
    Cell Cycle; 2012 Oct; 11(20):3715-7. PubMed ID: 22983005
    [No Abstract]   [Full Text] [Related]  

  • 5. Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells.
    Gemelli C; Montanari M; Tenedini E; Zanocco Marani T; Vignudelli T; Siena M; Zini R; Salati S; Tagliafico E; Manfredini R; Grande A; Ferrari S
    Cell Death Differ; 2006 Oct; 13(10):1686-96. PubMed ID: 16456583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
    Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
    Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.
    Boersma-Vreugdenhil GR; Kuipers J; Van Stralen E; Peeters T; Michaux L; Hagemeijer A; Pearson PL; Clevers HC; Bast BJ
    Br J Haematol; 2004 Aug; 126(3):355-63. PubMed ID: 15257707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining How the MAFB Transcription Factor Affects Islet β-Cell Function Postnatally.
    Cyphert HA; Walker EM; Hang Y; Dhawan S; Haliyur R; Bonatakis L; Avrahami D; Brissova M; Kaestner KH; Bhushan A; Powers AC; Stein R
    Diabetes; 2019 Feb; 68(2):337-348. PubMed ID: 30425060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.
    Chen Y; Wang T; Huang M; Liu Q; Hu C; Wang B; Han D; Chen C; Zhang J; Li Z; Liu C; Lei W; Chang Y; Wu M; Xiang D; Chen Y; Wang R; Huang W; Lei Z; Chu X
    Cancer Res; 2020 Jun; 80(12):2472-2483. PubMed ID: 32234710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma.
    Walker BA; Wardell CP; Murison A; Boyle EM; Begum DB; Dahir NM; Proszek PZ; Melchor L; Pawlyn C; Kaiser MF; Johnson DC; Qiang YW; Jones JR; Cairns DA; Gregory WM; Owen RG; Cook G; Drayson MT; Jackson GH; Davies FE; Morgan GJ
    Nat Commun; 2015 Apr; 6():6997. PubMed ID: 25904160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mouse mafB 5'-upstream fragment directs gene expression in myelomonocytic cells, differentiated macrophages and the ventral spinal cord in transgenic mice.
    Hamada M; Moriguchi T; Yokomizo T; Morito N; Zhang C; Takahashi S
    J Biochem; 2003 Aug; 134(2):203-10. PubMed ID: 12966068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neither MafA/L-Maf nor MafB is essential for lens development in mice.
    Takeuchi T; Kudo T; Ogata K; Hamada M; Nakamura M; Kito K; Abe Y; Ueda N; Yamamoto M; Engel JD; Takahashi S
    Genes Cells; 2009 Aug; 14(8):941-7. PubMed ID: 19624757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A LncRNA-MAF:MAFB transcription factor network regulates epidermal differentiation.
    Lopez-Pajares V; Qu K; Zhang J; Webster DE; Barajas BC; Siprashvili Z; Zarnegar BJ; Boxer LD; Rios EJ; Tao S; Kretz M; Khavari PA
    Dev Cell; 2015 Mar; 32(6):693-706. PubMed ID: 25805135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression patterns of MafB and c-Maf in macrophages in vivo and in vitro.
    Daassi D; Hamada M; Jeon H; Imamura Y; Nhu Tran MT; Takahashi S
    Biochem Biophys Res Commun; 2016 Apr; 473(1):118-124. PubMed ID: 26996125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal differentiation gene regulatory networks controlled by MAF and MAFB.
    Labott AT; Lopez-Pajares V
    Cell Cycle; 2016 Jun; 15(11):1405-9. PubMed ID: 27097296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma.
    Yang L; Wang H; Kornblau SM; Graber DA; Zhang N; Matthews JA; Wang M; Weber DM; Thomas SK; Shah JJ; Zhang L; Lu G; Zhao M; Muddasani R; Yoo SY; Baggerly KA; Orlowski RZ
    Oncogene; 2011 Mar; 30(11):1329-40. PubMed ID: 21057542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a novel gene, MafB, in Dupuytren's disease.
    Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J
    J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma.
    Qiang YW; Ye S; Huang Y; Chen Y; Van Rhee F; Epstein J; Walker BA; Morgan GJ; Davies FE
    BMC Cancer; 2018 Jul; 18(1):724. PubMed ID: 29980194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma.
    Suzuki A; Iida S; Kato-Uranishi M; Tajima E; Zhan F; Hanamura I; Huang Y; Ogura T; Takahashi S; Ueda R; Barlogie B; Shaughnessy J; Esumi H
    Oncogene; 2005 Oct; 24(46):6936-44. PubMed ID: 16044163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel transgenic mouse model of the human multiple myeloma chromosomal translocation t(14;16)(q32;q23).
    Morito N; Yoh K; Maeda A; Nakano T; Fujita A; Kusakabe M; Hamada M; Kudo T; Yamagata K; Takahashi S
    Cancer Res; 2011 Jan; 71(2):339-48. PubMed ID: 21224354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.